Munir Mosaheb

Excited to join @nimbletherapeutics as VP & Head of Biology! We’re developing novel oral peptide therapeutics using our groundbreaking platform #immunology #oralpeptide

Excited to share that Laronde & @sendabioscience have merged to form @SailBiomeds , a new company pioneering the design & deployment of fully programmable medicines to transform patient care! Follow us @SailBiomeds #FlagshipFounded #eRNA @FlagshipPioneer

Flagship launches Sail Biomedicines (@SailBiomeds), which combines #FlagshipFounded @endlessRNA and @sendabioscience, along with AI capabilities from Flagship Labs to form a new company pioneering the design and deployment of fully programmable medicines. More here: flagshippioneering.com/press/flagship…

#ipnc2023 it was a pleasure to be part of this panel and I really enjoyed meeting old friends and making new ones, thank you for inviting me to be a speaker on your panel

A novel subset of tissue-resident memory T cells may contribute to lung immunity during #pneumococcal #pneumonia mucosalimmunology.org/article/S1933-…

My new book is out today- ‘Show me the Science’- adapted from ‘Never mind the B*ll*cks Here’s the Science’ for teens by Shelia Armstrong who did a great job . You can order here: books.ie/show-me-the-sc… amazon.co.uk/Show-Me-Scienc…  #ShowMetheScience #GillBooksAW23

We are thrilled to be recognized on @fastcompany’s list of World Changing Ideas for our pioneering work to use nature’s codes to fully unlock #programmablemedicines & bring life-improving treatments to patients. Read more: sendabiosciences.com/press/senda-bi… #FCWorldChangingIdeas #SendRNA

Thrilled to be presenting Senda Biosciences exciting science at #DDSS2023

On @Big4Bio’s #CompanytoWatch podcast, we talk about how Senda is applying modeling and AI to our unique #SendAtlas to build a pipeline of new medicines. We’ll first focus on #immunotherapy, given the area’s unmet medical need. 🎙️ Listen here: bit.ly/3og4p6D

Excited to have an excellent immunologist Luke Oneill @laoneill111 join us @sendabioscience , looking forward to do some great science together sendabiosciences.com/press/senda-bi…

Today we welcome Dr. Luke O’Neill, a world-renowned immunologist, as our CSO. His valuable insights will be essential as we position our platform to focus initially on #programmablemedicines in #immunology. sendabiosciences.com/press/senda-bi…

I am thrilled to share that we have raised 123 million dollars for our Series C, paving the way for @sendabioscience to continue to build our platform and advance programmable medicine to patients

@felipe_pinh0 Congrats wish you all the best on your new adventure

We have landed!! #WashU #STL Happy independence 😉 day!

Celebrating a company milestone today, cutting the ribbon to officially open another 2,200 sq. ft. of brand new BSL2 lab space, complete with autoclave, glasswasher, and consumables storage. Pretty spiffy! #SendaScience #CreatingProgrammableMedicines

Happy Holidays everyone

Thank you @FierceBiotech for including us in the 2021 Fierce 15 list. We’re excited Fierce recognizes the promise of Intersystems Biology, our X-VIA™ platform and our work developing next-generation nucleic acid, genetic, and protein-based therapies. bit.ly/3AP8L6q

@MempelThorsten Congratulations @MempelThorsten very nice work

Thanks to the team at Cell for making our paper a free featured article 👍

We’re excited to announce that Senda’s CEO, Guillaume Pfefer, Ph.D., has been named to the 2021 #PharmaVoice100 Congratulations to Guillaume and all of this year's honorees. bit.ly/3ilbP3o

I am looking for two RA/Sr.RA to join my Translational Biology group at Senda Biosciences to join my immunology group to do some exciting science and develop new therapeutics for patients, apply to this position Check out this job from Senda Biosciences linkedin.com/jobs/view/2659…